DOSTARLIMAB

DOSTARLIMAB was reported 2493 times

DOSTARLIMAB is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 MUCINOUS ENDOMETRIAL CARCINOMA 1 0.5000
1 PERITONECTOMY 3 0.2727
2 CARCINOID TUMOUR OF THE MESENTERY 1 0.2500
3 IMMUNOTOXICITY 23 0.2018
4 ENDOMETRIAL CANCER RECURRENT 16 0.1221
5 ENDOMETRIAL CANCER STAGE IV 4 0.1081
6 SKIN GRAFT DETACHMENT 2 0.0833
7 PERITONEAL NEOPLASM 8 0.0748
8 OMENTECTOMY 3 0.0682
9 POLYRADICULONEUROPATHY 3 0.0577
10 ENDOMETRIAL CANCER METASTATIC 8 0.0494
11 ACUTE POLYNEUROPATHY 13 0.0455
12 DNA MISMATCH REPAIR PROTEIN GENE MUTATION 1 0.0417
13 MYOCARDITIS-MYOSITIS-MYASTHENIA GRAVIS OVERLAP SYNDROME 9 0.0395
14 PARANEOPLASTIC RASH 1 0.0357
15 ACQUIRED EPIDERMOLYSIS BULLOSA 4 0.0325
16 CYTOREDUCTIVE SURGERY 2 0.0323
17 AUTOIMMUNE MYOCARDITIS 7 0.0320
18 CERVIX CARCINOMA STAGE III 4 0.0305
19 ABDOMINAL WALL NEOPLASM 1 0.0294
20 HEREDITARY NON-POLYPOSIS COLORECTAL CANCER SYNDROME 2 0.0286
21 AUTOIMMUNE THYROID DISORDER 3 0.0275
22 IMMUNE-MEDIATED GASTRITIS 5 0.0260
23 ABDOMINAL WALL MASS 3 0.0246
24 PRODUCT SELECTION ISSUE 1 0.0238
25 BLOOD PYRUVIC ACID INCREASED 1 0.0213
26 IMMUNE-MEDIATED ARTHRITIS 8 0.0210
27 CERVIX CARCINOMA STAGE IV 3 0.0207
28 ENDOCRINE TOXICITY 2 0.0196
29 IMMUNE-MEDIATED NEPHRITIS 9 0.0192
30 ADRENALITIS 2 0.0187
31 AUTOIMMUNE ANAEMIA 1 0.0182
32 BOWEL OBSTRUCTION SURGERY 1 0.0182
33 PULMONARY HILAR ENLARGEMENT 1 0.0179
34 OCCIPITAL LOBE STROKE 1 0.0169
35 SALPINGO-OOPHORECTOMY 2 0.0168
36 ACUTE MONOCYTIC LEUKAEMIA 3 0.0165
37 ECHOPRAXIA 1 0.0154
38 FAECAL VOMITING 8 0.0150
39 GASTROINTESTINAL MUCOSAL EXFOLIATION 2 0.0150
40 MALIGNANT MESENTERIC NEOPLASM 1 0.0132
41 INFECTED LYMPHOCELE 1 0.0127
42 ENDOMETRIAL CANCER STAGE III 1 0.0127
43 ADENOCARCINOMA OF THE CERVIX 2 0.0123
44 APPENDICEAL ABSCESS 3 0.0123
45 IATROGENIC INFECTION 1 0.0122
46 CYSTITIS KLEBSIELLA 2 0.0119
47 ACUTE HAEMORRHAGIC ULCERATIVE COLITIS 1 0.0116
48 IMMUNE-MEDIATED NEUROLOGICAL DISORDER 1 0.0115
49 URETERAL STENT INSERTION 4 0.0115
50 IMMUNE-MEDIATED ADRENAL INSUFFICIENCY 9 0.0113
51 IMMUNE-MEDIATED LUNG DISEASE 20 0.0110
52 STARVATION 9 0.0108
53 PNEUMATURIA 1 0.0104
54 IIIRD NERVE PARALYSIS 8 0.0099
55 IMMUNE-MEDIATED HYPOTHYROIDISM 11 0.0098
56 OTITIS MEDIA ACUTE 7 0.0095
57 ENDOMETRIAL CANCER 20 0.0091
58 CENTRAL HYPOTHYROIDISM 3 0.0091
59 IMMUNE-MEDIATED CYSTITIS 1 0.0087
60 IMMUNE-MEDIATED MYOCARDITIS 14 0.0087
61 OPTIC DISC OEDEMA 1 0.0086
62 UROGENITAL FISTULA 2 0.0084
63 AUTOIMMUNE HYPOTHYROIDISM 2 0.0084
64 GAMMA-GLUTAMYLTRANSFERASE ABNORMAL 5 0.0083
65 IMMUNE-MEDIATED PANCREATITIS 3 0.0079
66 IMMUNE-MEDIATED HEPATITIS 16 0.0078
67 CERVIX NEOPLASM 1 0.0073
68 IMMUNE-MEDIATED ADVERSE REACTION 11 0.0072
69 SARCOPENIA 3 0.0069
70 TISSUE INFILTRATION 2 0.0068
71 IMMUNE-MEDIATED ENDOCRINOPATHY 1 0.0067
72 METASTASES TO HEART 2 0.0066
73 OVARIAN VEIN THROMBOSIS 1 0.0066
74 ORBITAL MYOSITIS 1 0.0066
75 LAPAROTOMY 3 0.0066
76 IMMUNE-MEDIATED NEUROPATHY 1 0.0065
77 PERITONEAL DISORDER 4 0.0062
78 PELVIC ABSCESS 7 0.0061
79 ENDOMETRIAL CANCER STAGE I 1 0.0060
80 NERVE CONDUCTION STUDIES ABNORMAL 1 0.0060
81 PAPILLITIS 1 0.0060
82 AORTITIS 4 0.0058
83 PULMONARY RENAL SYNDROME 2 0.0057
84 PRODUCT DOSE CONFUSION 2 0.0056
85 SYMPTOM MASKED 4 0.0055
86 ALOPECIA SCARRING 1 0.0055
87 BRONCHOPNEUMOPATHY 2 0.0054
88 INTENSIVE CARE UNIT ACQUIRED WEAKNESS 2 0.0053
89 CYSTITIS RADIATION 1 0.0052
90 MYASTHENIC SYNDROME 4 0.0052
91 MALIGNANT NEOPLASM OLIGOPROGRESSION 1 0.0050
92 IMMUNE-MEDIATED DERMATITIS 5 0.0050
93 AUTOIMMUNE HAEMOLYTIC ANAEMIA 17 0.0050
94 IMMUNE-MEDIATED RENAL DISORDER 2 0.0048
95 PRIMARY HYPOTHYROIDISM 1 0.0047
96 ADULT FAILURE TO THRIVE 1 0.0047
97 URINARY TRACT INFECTION STAPHYLOCOCCAL 2 0.0047
98 HAEMOPHILIA 1 0.0047
99 MYOCARDITIS 49 0.0043
100 THYROXINE INCREASED 3 0.0042
101 GRANULOMATOUS DERMATITIS 1 0.0041
102 AORTIC VALVE SCLEROSIS 3 0.0041
103 POLYMYALGIA RHEUMATICA 13 0.0041
104 ADRENAL INSUFFICIENCY 49 0.0040
105 HYPOPHYSITIS 8 0.0040
106 ANORECTAL INFECTION 1 0.0040
107 HYPONATRAEMIC SEIZURE 1 0.0039
108 PERITONEAL ADHESIONS 1 0.0039
109 IMMUNE-MEDIATED HYPERTHYROIDISM 1 0.0039
110 DRAIN PLACEMENT 1 0.0039
111 URTICARIAL VASCULITIS 2 0.0038
112 IMMUNE-MEDIATED ENCEPHALITIS 2 0.0038
113 PROCTECTOMY 1 0.0036
114 ORGANISING PNEUMONIA 18 0.0036
115 BLOOD MAGNESIUM ABNORMAL 2 0.0036
116 NEPHRITIS 12 0.0036
117 OESOPHAGITIS HAEMORRHAGIC 1 0.0036
118 ENCEPHALOMALACIA 2 0.0036
119 SKIN TOXICITY 20 0.0035
120 TOXIC SKIN ERUPTION 35 0.0035
121 DERMO-HYPODERMITIS 2 0.0034
122 PROCTITIS ULCERATIVE 2 0.0033
123 CREATININE URINE INCREASED 1 0.0033
124 RENAL NEOPLASM 7 0.0033
125 PROCTOCOLECTOMY 1 0.0033
126 IMMUNE-MEDIATED ENTEROCOLITIS 12 0.0033
127 EXTENSOR PLANTAR RESPONSE 3 0.0033
128 PALATAL OEDEMA 4 0.0032
129 DEVICE RELATED BACTERAEMIA 1 0.0032
130 MEDICAL DEVICE SITE INFECTION 2 0.0032
131 IMMUNE-MEDIATED MYASTHENIA GRAVIS 1 0.0031
132 LICHENOID KERATOSIS 7 0.0031
133 ENCEPHALITIS AUTOIMMUNE 4 0.0030
134 CELL DEATH 6 0.0030
135 METASTASES TO BREAST 1 0.0030
136 NEUROMYELITIS OPTICA SPECTRUM DISORDER 4 0.0030
137 STEROID WITHDRAWAL SYNDROME 3 0.0029
138 TUMOUR FLARE 2 0.0029
139 DERMATITIS BULLOUS 21 0.0029
140 EOSINOPHILIC FASCIITIS 1 0.0029
141 PROCTITIS 8 0.0029
142 FUNGAL OESOPHAGITIS 2 0.0028
143 CYTOMEGALOVIRUS HEPATITIS 1 0.0028
144 STREPTOCOCCAL BACTERAEMIA 3 0.0028
145 MYOSITIS 24 0.0027
146 FEBRILE BONE MARROW APLASIA 11 0.0026
147 LICHEN PLANUS 6 0.0026
148 PERIPHERAL SENSORY NEUROPATHY 15 0.0026
149 MYOCARDIAL OEDEMA 1 0.0025
150 TYPE 1 DIABETES MELLITUS 15 0.0025
151 MALIGNANT NEOPLASM PROGRESSION 254 0.0025
152 GLUCOCORTICOID DEFICIENCY 1 0.0024
153 CAROTID ARTERY DISSECTION 1 0.0023
154 CUTANEOUS SARCOIDOSIS 1 0.0023
155 ABDOMINAL LYMPHADENOPATHY 2 0.0023
156 AUTOIMMUNE HEPATITIS 16 0.0023
157 HYPOPITUITARISM 4 0.0023
158 FACIAL NERVE DISORDER 1 0.0023
159 HAEMORRHAGIC DIATHESIS 8 0.0022
160 CONGESTIVE HEPATOPATHY 1 0.0022
161 IMMUNE-MEDIATED HYPOPHYSITIS 1 0.0022
162 GASTROINTESTINAL STENOSIS 1 0.0022
163 BIOPSY BONE MARROW ABNORMAL 1 0.0022
164 ORAL FUNGAL INFECTION 6 0.0022
165 BILIARY SEPSIS 1 0.0022
166 SMALL INTESTINAL PERFORATION 4 0.0021
167 RASH MACULO-PAPULAR 47 0.0021
168 KERATIC PRECIPITATES 1 0.0021
169 INTESTINAL ANGIOEDEMA 1 0.0021
170 BLOOD THYROID STIMULATING HORMONE 1 0.0021
171 HYPOTHYROIDISM 66 0.0021
172 PULMONARY SEPSIS 3 0.0021
173 ADRENOCORTICAL INSUFFICIENCY ACUTE 4 0.0020
174 BICYTOPENIA 4 0.0020
175 DRAINAGE 1 0.0020
176 ELECTROLYTE DEPLETION 1 0.0020
177 IMMUNE-MEDIATED THYROIDITIS 1 0.0020
178 MYASTHENIA GRAVIS CRISIS 3 0.0020
179 STEROID DIABETES 3 0.0020
180 TROPONIN INCREASED 15 0.0020
181 IRIS ADHESIONS 1 0.0019
182 DEMYELINATING POLYNEUROPATHY 2 0.0019
183 PALMOPLANTAR PUSTULOSIS 1 0.0019
184 STRESS CARDIOMYOPATHY 11 0.0019
185 HEPATIC CYTOLYSIS 24 0.0019
186 TUMOUR PSEUDOPROGRESSION 2 0.0018
187 IMMUNE-MEDIATED MYOSITIS 5 0.0018
188 OCULAR TOXICITY 2 0.0018
189 HYPERTENSIVE URGENCY 1 0.0018
190 MYOCARDIAL INJURY 2 0.0018
191 MECHANICAL ILEUS 1 0.0018
192 CORTISOL DECREASED 2 0.0017
193 ENCEPHALITIS 12 0.0017
194 METHAEMOGLOBINAEMIA 4 0.0017
195 ANTIPHOSPHOLIPID ANTIBODIES POSITIVE 1 0.0017
196 RECTAL ULCER 2 0.0017
197 MALIGNANT PERITONEAL NEOPLASM 1 0.0017
198 COLON OPERATION 2 0.0017
199 THYROIDITIS 5 0.0017
200 PERIPHERAL SENSORIMOTOR NEUROPATHY 2 0.0016
201 HYPERTHYROIDISM 23 0.0016
202 TROPONIN T INCREASED 2 0.0016
203 CHOLINERGIC SYNDROME 1 0.0016
204 ANAL INFLAMMATION 1 0.0016
205 GLIOMA 1 0.0016
206 MAGNETIC RESONANCE IMAGING HEAD ABNORMAL 1 0.0015
207 CHONDROCALCINOSIS 1 0.0015
208 PARANEOPLASTIC SYNDROME 1 0.0015
209 RECURRENT CANCER 6 0.0015
210 LICHEN SCLEROSUS 1 0.0015
211 OESOPHAGITIS ULCERATIVE 1 0.0015
212 CYTOKINE STORM 1 0.0015
213 LEFT VENTRICULAR FAILURE 5 0.0015
214 RASH MORBILLIFORM 4 0.0014
215 DIABETIC METABOLIC DECOMPENSATION 2 0.0014
216 SUBILEUS 3 0.0014
217 POSITRON EMISSION TOMOGRAM ABNORMAL 1 0.0014
218 PERIPHERAL MOTOR NEUROPATHY 2 0.0014
219 GRANULOMATOUS LIVER DISEASE 1 0.0014
220 MYELITIS TRANSVERSE 2 0.0014
221 CERVICAL RADICULOPATHY 1 0.0014
222 CRYOGLOBULINAEMIA 1 0.0014
223 POST HERPETIC NEURALGIA 2 0.0014
224 TUBULOINTERSTITIAL NEPHRITIS 26 0.0014
225 ACCOMMODATION DISORDER 1 0.0014
226 MYASTHENIA GRAVIS 11 0.0014
227 HEPATITIS 34 0.0013
228 SUSPECTED OFF LABEL USE 6 0.0013
229 POLYARTHRITIS 7 0.0013
230 CHOLANGITIS ACUTE 1 0.0013
231 SECONDARY ADRENOCORTICAL INSUFFICIENCY 2 0.0013
232 BONE MARROW DISORDER 4 0.0013
233 BLOOD THYROID STIMULATING HORMONE DECREASED 6 0.0013
234 COLITIS 50 0.0013
235 MYOCLONIC EPILEPSY 2 0.0013
236 MONOCLONAL IMMUNOGLOBULIN PRESENT 1 0.0013
237 COAGULATION TEST ABNORMAL 1 0.0013
238 BLOOD KETONE BODY INCREASED 1 0.0013
239 VENOUS THROMBOSIS 5 0.0013
240 OPHTHALMOPLEGIA 2 0.0013
241 COLORECTAL CANCER METASTATIC 3 0.0013
242 PRODUCT CONFUSION 1 0.0013
243 POLYNEUROPATHY 15 0.0013
244 PNEUMONITIS 34 0.0012
245 HAPTOGLOBIN DECREASED 1 0.0012
246 PANNICULITIS 3 0.0012
247 OXYGEN THERAPY 2 0.0012
248 LINEAR IGA DISEASE 2 0.0012
249 PEMPHIGOID 9 0.0012
250 MYOCARDIAL FIBROSIS 1 0.0012
251 HEPATORENAL SYNDROME 2 0.0012
252 CEREBRAL VENOUS SINUS THROMBOSIS 1 0.0012
253 WOUND DEHISCENCE 4 0.0012
254 ILEOSTOMY 3 0.0012
255 ABNORMAL LOSS OF WEIGHT 8 0.0012
256 PHLEBITIS 6 0.0012
257 FEMALE GENITAL TRACT FISTULA 2 0.0012
258 HAEMATOTOXICITY 11 0.0012
259 POSTMENOPAUSAL HAEMORRHAGE 3 0.0011
260 AXONAL NEUROPATHY 1 0.0011
261 PRODUCT USE IN UNAPPROVED THERAPEUTIC ENVIRONMENT 1 0.0011
262 SUBACUTE CUTANEOUS LUPUS ERYTHEMATOSUS 2 0.0011
263 AREFLEXIA 3 0.0011
264 ABDOMINAL NEOPLASM 1 0.0011
265 TYPE IV HYPERSENSITIVITY REACTION 3 0.0011
266 IMMUNE THROMBOCYTOPENIA 5 0.0011
267 BLOOD THYROID STIMULATING HORMONE ABNORMAL 2 0.0011
268 PRODUCT PREPARATION ISSUE 7 0.0011
269 BUNDLE BRANCH BLOCK 1 0.0011
270 ISCHAEMIC STROKE 19 0.0011
271 INTERVERTEBRAL DISCITIS 2 0.0011
272 CATHETER SITE INFECTION 4 0.0011
273 NEUTROPENIC INFECTION 1 0.0010
274 GUILLAIN-BARRE SYNDROME 5 0.0010
275 MASTOIDITIS 1 0.0010
276 PYELONEPHRITIS ACUTE 2 0.0010
277 DEVICE RELATED THROMBOSIS 1 0.0010
278 OBSTRUCTION 4 0.0010
279 RECTAL CANCER 3 0.0010
280 CORONAVIRUS TEST POSITIVE 1 0.0010
281 METASTASES TO SKIN 1 0.0010
282 DIABETIC KETOACIDOSIS 23 0.0010
283 METASTASES TO PLEURA 1 0.0010
284 BLOOD SODIUM ABNORMAL 1 0.0009
285 RADIATION PNEUMONITIS 2 0.0009
286 PYELONEPHRITIS 8 0.0009
287 HEPATITIS ACUTE 6 0.0009
288 GLOMERULONEPHRITIS RAPIDLY PROGRESSIVE 1 0.0009
289 BENIGN NEOPLASM 1 0.0009
290 CARBOHYDRATE ANTIGEN 125 INCREASED 3 0.0009
291 FOLATE DEFICIENCY 1 0.0009
292 LUMBAR RADICULOPATHY 1 0.0009
293 HYPERTRANSAMINASAEMIA 6 0.0009
294 PAROTITIS 1 0.0009
295 NEUROPATHY PERIPHERAL 82 0.0009
296 FEBRILE INFECTION 1 0.0008
297 HORMONE-REFRACTORY PROSTATE CANCER 1 0.0008
298 MAGNETIC RESONANCE IMAGING ABNORMAL 1 0.0008
299 GASTROINTESTINAL TOXICITY 4 0.0008
300 MYELODYSPLASTIC SYNDROME 12 0.0008
301 RENAL TUBULAR NECROSIS 8 0.0008
302 LARGE INTESTINE INFECTION 1 0.0008
303 MYOPATHY 7 0.0008
304 CHOLANGITIS 5 0.0008
305 FRACTURED SACRUM 1 0.0008
306 HYPERAESTHESIA TEETH 1 0.0008
307 METASTASES TO PERITONEUM 2 0.0008
308 DERMATOMYOSITIS 2 0.0008
309 OBSTRUCTION GASTRIC 1 0.0008
310 LUNG OPACITY 2 0.0008
311 CARBON DIOXIDE INCREASED 1 0.0007
312 EMBOLISM 6 0.0007
313 THROMBOTIC MICROANGIOPATHY 7 0.0007
314 THROMBOCYTOPENIA 80 0.0007
315 THYROID DISORDER 11 0.0007
316 MAST CELL ACTIVATION SYNDROME 1 0.0007
317 ANKLE FRACTURE 11 0.0007
318 PRERENAL FAILURE 1 0.0007
319 ALVEOLITIS 1 0.0007
320 BUNDLE BRANCH BLOCK LEFT 3 0.0007
321 GLOMERULAR FILTRATION RATE ABNORMAL 1 0.0007
322 TUMOUR HAEMORRHAGE 2 0.0007
323 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 18 0.0007
324 PELVIC VENOUS THROMBOSIS 1 0.0007
325 METASTASES TO CENTRAL NERVOUS SYSTEM 9 0.0007
326 HYSTERECTOMY 6 0.0007
327 MUCOSAL INFLAMMATION 18 0.0007
328 PANCREATIC ENZYMES INCREASED 1 0.0007
329 GASTROINTESTINAL WALL THICKENING 1 0.0007
330 HYDRONEPHROSIS 5 0.0007
331 IRON DEFICIENCY 3 0.0007
332 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 5 0.0007
333 URINARY TRACT DISORDER 3 0.0007
334 PAPILLOEDEMA 3 0.0007
335 INFECTIOUS PLEURAL EFFUSION 1 0.0007
336 PARAINFLUENZAE VIRUS INFECTION 1 0.0007
337 ASPARTATE AMINOTRANSFERASE ABNORMAL 1 0.0007
338 DUODENITIS 2 0.0007
339 MYELITIS 1 0.0006
340 ONYCHOLYSIS 1 0.0006
341 IRIDOCYCLITIS 2 0.0006
342 STEVENS-JOHNSON SYNDROME 14 0.0006
343 INTESTINAL PERFORATION 7 0.0006
344 OVARIAN CANCER RECURRENT 1 0.0006
345 GLYCOSYLATED HAEMOGLOBIN DECREASED 1 0.0006
346 AORTIC VALVE DISEASE 1 0.0006
347 INTERSTITIAL LUNG DISEASE 30 0.0006
348 PITUITARY TUMOUR BENIGN 1 0.0006
349 METASTASES TO BONE 10 0.0006
350 METASTASES TO LUNG 7 0.0006
351 MYOCARDIAL NECROSIS MARKER INCREASED 1 0.0006
352 LUNG DISORDER 29 0.0006
353 ENDOCARDITIS 3 0.0006
354 FIXED ERUPTION 1 0.0006
355 BLOOD CREATININE ABNORMAL 2 0.0006
356 DERMATITIS EXFOLIATIVE GENERALISED 2 0.0006
357 PANCREATIC FAILURE 1 0.0006
358 JUGULAR VEIN THROMBOSIS 1 0.0006
359 HAEMOLYTIC ANAEMIA 5 0.0006
360 BODY TEMPERATURE ABNORMAL 1 0.0005
361 HEPATOTOXICITY 12 0.0005
362 NEURODERMATITIS 2 0.0005
363 INTERMENSTRUAL BLEEDING 3 0.0005
364 KETOACIDOSIS 4 0.0005
365 NEUTROPHILIA 3 0.0005
366 ARTERIAL DISORDER 1 0.0005
367 LYMPHADENOPATHY MEDIASTINAL 1 0.0005
368 ADRENAL DISORDER 1 0.0005
369 GINGIVAL RECESSION 1 0.0005
370 ENTEROCOLITIS 3 0.0005
371 ANAEMIA 98 0.0005
372 IMMUNE-MEDIATED HEPATIC DISORDER 1 0.0005
373 DERMATITIS PSORIASIFORM 1 0.0005
374 ARTHRITIS BACTERIAL 2 0.0005
375 HYPERURICAEMIA 2 0.0005
376 INFUSION SITE EXTRAVASATION 3 0.0005
377 BODY TEMPERATURE FLUCTUATION 1 0.0005
378 ALANINE AMINOTRANSFERASE ABNORMAL 1 0.0005
379 OPTIC NEUROPATHY 1 0.0005
380 ENTERITIS 3 0.0005
381 ACUTE RESPIRATORY FAILURE 9 0.0005
382 EXOPHTHALMOS 1 0.0005
383 HAEMORRHOIDS 9 0.0005
384 TOXIC EPIDERMAL NECROLYSIS 7 0.0005
385 DRUG ERUPTION 8 0.0005
386 CHOLESTATIC LIVER INJURY 1 0.0004
387 LEFT VENTRICULAR DYSFUNCTION 3 0.0004
388 LARGE INTESTINAL OBSTRUCTION 1 0.0004
389 MENINGITIS ASEPTIC 2 0.0004
390 UVEITIS 6 0.0004
391 GENERAL PHYSICAL CONDITION ABNORMAL 3 0.0004
392 NEUTROPENIA 60 0.0004
393 NEPHROTIC SYNDROME 3 0.0004
394 CYTOMEGALOVIRUS COLITIS 1 0.0004
395 BLOOD THYROID STIMULATING HORMONE INCREASED 4 0.0004
396 FLAT AFFECT 1 0.0004
397 HAEMOLYTIC URAEMIC SYNDROME 1 0.0004
398 BILIRUBIN CONJUGATED INCREASED 1 0.0004
399 SKIN REACTION 6 0.0004
400 ESCHERICHIA BACTERAEMIA 1 0.0004
401 SARCOIDOSIS 2 0.0004
402 METASTASIS 3 0.0004
403 INTRA-ABDOMINAL HAEMORRHAGE 1 0.0004
404 EYE INFLAMMATION 4 0.0004
405 CHOLESTASIS 8 0.0004
406 AUTOIMMUNE DISORDER 4 0.0004
407 CYTOPENIA 5 0.0004
408 SENSITIVE SKIN 3 0.0004
409 STAPHYLOCOCCAL SEPSIS 2 0.0004
410 TRANSAMINASES INCREASED 9 0.0004
411 INFLAMMATORY MARKER INCREASED 2 0.0004
412 NEUROTOXICITY 7 0.0004
413 PANCYTOPENIA 22 0.0004
414 EYELID PTOSIS 4 0.0004
415 HYPERTHERMIA 3 0.0004
416 LIPASE INCREASED 3 0.0004
417 ABDOMINAL INFECTION 1 0.0004
418 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 4 0.0004
419 PHYSICAL DECONDITIONING 1 0.0004
420 APHTHOUS ULCER 3 0.0004
421 POOR VENOUS ACCESS 4 0.0004
422 APLASTIC ANAEMIA 2 0.0004
423 DERMATITIS 8 0.0004
424 GENERAL PHYSICAL HEALTH DETERIORATION 44 0.0004
425 EXFOLIATIVE RASH 1 0.0004
426 TRICUSPID VALVE INCOMPETENCE 3 0.0004
427 GINGIVAL PAIN 3 0.0004
428 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 1 0.0004
429 GASTROINTESTINAL MOTILITY DISORDER 2 0.0004
430 UTERINE CANCER 3 0.0004
431 BREAST SWELLING 1 0.0004
432 LARGE INTESTINAL ULCER 1 0.0004
433 MIGRAINE WITH AURA 1 0.0004
434 INVASIVE DUCTAL BREAST CARCINOMA 1 0.0004
435 OESOPHAGITIS 4 0.0004
436 SKIN LESION 10 0.0004
437 PLEURITIC PAIN 1 0.0004
438 GASTRIC ULCER HAEMORRHAGE 2 0.0004
439 SECOND PRIMARY MALIGNANCY 3 0.0004
440 MALNUTRITION 4 0.0004
441 LUNG CONSOLIDATION 1 0.0004
442 ENDOTRACHEAL INTUBATION 1 0.0004
443 PSYCHOMOTOR RETARDATION 1 0.0004
444 NEUTROPHIL COUNT ABNORMAL 1 0.0004
445 NECK MASS 1 0.0004
446 CEREBRAL THROMBOSIS 1 0.0004
447 PANCREATIC CARCINOMA METASTATIC 1 0.0004
448 PNEUMATOSIS INTESTINALIS 1 0.0004
449 NEUROLOGICAL SYMPTOM 2 0.0003
450 DYSPNOEA AT REST 1 0.0003
451 GASTROINTESTINAL NECROSIS 1 0.0003
452 GASTRITIS 9 0.0003
453 NECK INJURY 1 0.0003
454 CARDIOMYOPATHY 5 0.0003
455 INFUSION SITE REACTION 1 0.0003
456 ATYPICAL PNEUMONIA 1 0.0003
457 MIXED LIVER INJURY 1 0.0003
458 FEBRILE NEUTROPENIA 22 0.0003
459 CENTRAL VENOUS CATHETERISATION 1 0.0003
460 LIP DRY 3 0.0003
461 KERATITIS 1 0.0003
462 DYSCHEZIA 1 0.0003
463 FIBROSIS 1 0.0003
464 SMALL INTESTINAL OBSTRUCTION 4 0.0003
465 DIASTOLIC DYSFUNCTION 1 0.0003
466 SEPTIC SHOCK 14 0.0003
467 ERYTHEMA MULTIFORME 3 0.0003
468 INTESTINAL OBSTRUCTION 12 0.0003
469 DERMATITIS ALLERGIC 4 0.0003
470 SUPRAVENTRICULAR TACHYCARDIA 3 0.0003
471 PANCREATITIS ACUTE 7 0.0003
472 HAEMOGLOBIN ABNORMAL 2 0.0003
473 ATELECTASIS 3 0.0003
474 PORTAL VEIN THROMBOSIS 1 0.0003
475 URINARY RETENTION 10 0.0003
476 MENINGITIS 2 0.0003
477 LUNG CARCINOMA CELL TYPE UNSPECIFIED STAGE IV 1 0.0003
478 NEOPLASM RECURRENCE 1 0.0003
479 PULMONARY EMBOLISM 28 0.0003
480 ALANINE AMINOTRANSFERASE INCREASED 18 0.0003
481 EYE MOVEMENT DISORDER 2 0.0003
482 APLASIA PURE RED CELL 1 0.0003
483 NEOPLASM PROGRESSION 10 0.0003
484 AORTIC STENOSIS 1 0.0003
485 DEFAECATION URGENCY 2 0.0003
486 ERYTHEMA NODOSUM 1 0.0003
487 METASTASES TO LIVER 5 0.0003
488 SUDDEN DEATH 3 0.0003
489 PULMONARY TOXICITY 2 0.0003
490 FACIAL PARESIS 1 0.0003
491 HYPOKALAEMIA 13 0.0003
492 NEUTROPENIC SEPSIS 2 0.0003
493 CARDIOGENIC SHOCK 4 0.0003
494 VAGINAL HAEMORRHAGE 12 0.0003
495 ORAL DISORDER 2 0.0003
496 AMYLASE INCREASED 1 0.0003
497 PULMONARY MASS 4 0.0003
498 NEPHROPATHY TOXIC 3 0.0003
499 PROTEIN TOTAL DECREASED 1 0.0003
500 MITRAL VALVE INCOMPETENCE 3 0.0003
501 HYPOCALCAEMIA 5 0.0003
502 CONJUNCTIVAL HAEMORRHAGE 1 0.0003
503 RASH 114 0.0003
504 OESOPHAGEAL ULCER 1 0.0003
505 OPTIC ISCHAEMIC NEUROPATHY 1 0.0003
506 PRODUCT USE IN UNAPPROVED INDICATION 64 0.0003
507 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 6 0.0003
508 EJECTION FRACTION DECREASED 4 0.0003
509 FAECES HARD 1 0.0003
510 LYMPHADENOPATHY 9 0.0003
511 BLOOD LACTATE DEHYDROGENASE INCREASED 4 0.0003
512 PNEUMOTHORAX 4 0.0003
513 SEPSIS 28 0.0003
514 CEREBRAL ATROPHY 1 0.0003
515 BLEPHARITIS 1 0.0002
516 BURSITIS 3 0.0002
517 FEEDING DISORDER 5 0.0002
518 ASPARTATE AMINOTRANSFERASE INCREASED 13 0.0002
519 BLOOD ALKALINE PHOSPHATASE INCREASED 6 0.0002
520 ACUTE CORONARY SYNDROME 2 0.0002
521 LEUKOPENIA 12 0.0002
522 RASH PRURITIC 13 0.0002
523 ASCITES 7 0.0002
524 SENSATION OF FOREIGN BODY 2 0.0002
525 INTESTINAL STENOSIS 1 0.0002
526 CARDIAC FAILURE 19 0.0002
527 ESCHERICHIA URINARY TRACT INFECTION 1 0.0002
528 METASTATIC NEOPLASM 1 0.0002
529 BLOOD MAGNESIUM DECREASED 2 0.0002
530 HEPATIC LESION 1 0.0002
531 CHAPPED LIPS 1 0.0002
532 PRODUCT PRESCRIBING ISSUE 5 0.0002
533 MELANOCYTIC NAEVUS 1 0.0002
534 IMMUNE SYSTEM DISORDER 3 0.0002
535 TUMOUR LYSIS SYNDROME 2 0.0002
536 PANCREATITIS 12 0.0002
537 GINGIVAL SWELLING 1 0.0002
538 ABDOMINAL ABSCESS 1 0.0002
539 BLOOD CREATINE INCREASED 1 0.0002
540 RASH PAPULAR 5 0.0002
541 BONE PAIN 13 0.0002
542 BLOOD PRESSURE SYSTOLIC DECREASED 1 0.0002
543 HYPERGLYCAEMIA 8 0.0002
544 EAR DISORDER 1 0.0002
545 LUMBAR VERTEBRAL FRACTURE 1 0.0002
546 LACTIC ACIDOSIS 7 0.0002
547 LOCALISED OEDEMA 1 0.0002
548 INTERCEPTED MEDICATION ERROR 1 0.0002
549 HYPOMAGNESAEMIA 3 0.0002
550 MASS 3 0.0002
551 FEELING OF DESPAIR 1 0.0002
552 PHOTOPHOBIA 4 0.0002
553 CARDIAC TAMPONADE 1 0.0002
554 ARTHRALGIA 87 0.0002
555 HYPOVOLAEMIC SHOCK 1 0.0002
556 NON-SMALL CELL LUNG CANCER 1 0.0002
557 CARDIAC ARREST 17 0.0002
558 RESPIRATORY FAILURE 15 0.0002
559 HOSPICE CARE 2 0.0002
560 HYPERVOLAEMIA 1 0.0002
561 DELIRIUM 7 0.0002
562 ABDOMINAL TENDERNESS 1 0.0002
563 DERMATITIS EXFOLIATIVE 1 0.0002
564 CYTOKINE RELEASE SYNDROME 4 0.0002
565 ANAPHYLACTIC REACTION 11 0.0002
566 ERYSIPELAS 1 0.0002
567 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 1 0.0002
568 DIABETES MELLITUS 15 0.0002
569 HYPONATRAEMIA 11 0.0002
570 CACHEXIA 1 0.0002
571 CEREBRAL ISCHAEMIA 1 0.0002
572 TENDERNESS 2 0.0002
573 BRAIN FOG 3 0.0002
574 HEPATIC ENZYME INCREASED 13 0.0002
575 ARTHRITIS 15 0.0002
576 ULCER 3 0.0002
577 PLATELET COUNT DECREASED 20 0.0002
578 COMPRESSION FRACTURE 1 0.0002
579 OVERWEIGHT 1 0.0002
580 ANAL ABSCESS 1 0.0002
581 BLOOD BILIRUBIN INCREASED 5 0.0002
582 CHEILITIS 1 0.0002
583 BLOOD CREATININE INCREASED 12 0.0002
584 BLOOD GLUCOSE FLUCTUATION 2 0.0002
585 VENTRICULAR TACHYCARDIA 3 0.0002
586 INTESTINAL ISCHAEMIA 1 0.0002
587 GAMMA-GLUTAMYLTRANSFERASE INCREASED 4 0.0002
588 NECROSIS 1 0.0002
589 INTRACRANIAL PRESSURE INCREASED 1 0.0002
590 PYREXIA 62 0.0002
591 ANGIOPATHY 1 0.0002
592 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 3 0.0002
593 CIRCULATORY COLLAPSE 3 0.0002
594 PERONEAL NERVE PALSY 1 0.0002
595 URINARY TRACT INFECTION 30 0.0002
596 ERYTHEMA 36 0.0002
597 ATRIAL FIBRILLATION 17 0.0002
598 CONDITION AGGRAVATED 53 0.0002
599 NEOPLASM 2 0.0002
600 GASTRIC HAEMORRHAGE 2 0.0002
601 MOUTH SWELLING 1 0.0002
602 DRY MOUTH 14 0.0002
603 HYPERVENTILATION 1 0.0002
604 ELECTROLYTE IMBALANCE 2 0.0002
605 ABDOMINAL PAIN 40 0.0002
606 HYPERTRIGLYCERIDAEMIA 1 0.0002
607 FATIGUE 133 0.0002
608 SPLENOMEGALY 2 0.0002
609 ACUTE KIDNEY INJURY 26 0.0002
610 ACUTE RESPIRATORY DISTRESS SYNDROME 3 0.0002
611 ACUTE MYOCARDIAL INFARCTION 5 0.0002
612 BRADYKINESIA 1 0.0002
613 DEEP VEIN THROMBOSIS 11 0.0002
614 GLUCOSE TOLERANCE IMPAIRED 1 0.0002
615 BACTERAEMIA 2 0.0002
616 PLEURISY 1 0.0002
617 THIRST 3 0.0002
618 CARDIAC PACEMAKER INSERTION 1 0.0002
619 HEPATITIS CHOLESTATIC 1 0.0002
620 OFF LABEL USE 145 0.0002
621 PLATELET COUNT ABNORMAL 1 0.0002
622 C-REACTIVE PROTEIN INCREASED 6 0.0002
623 END STAGE RENAL DISEASE 3 0.0002
624 ENCEPHALOPATHY 4 0.0002
625 LARYNGEAL OEDEMA 1 0.0002
626 PIGMENTATION DISORDER 1 0.0002
627 DRUG-INDUCED LIVER INJURY 5 0.0002
628 PULMONARY FIBROSIS 3 0.0002
629 THERAPY NON-RESPONDER 7 0.0002
630 PROCTALGIA 1 0.0002
631 INCOHERENT 1 0.0002
632 DYSPHONIA 9 0.0002
633 DISEASE PROGRESSION 18 0.0002
634 DYSGRAPHIA 1 0.0002
635 APPETITE DISORDER 1 0.0002
636 POST-TRAUMATIC STRESS DISORDER 1 0.0001
637 FEELING HOT 9 0.0001
638 IMPAIRED GASTRIC EMPTYING 2 0.0001
639 ACUTE HEPATIC FAILURE 2 0.0001
640 CENTRAL NERVOUS SYSTEM LESION 2 0.0001
641 JOINT EFFUSION 1 0.0001
642 LYMPHOEDEMA 1 0.0001
643 MENTAL STATUS CHANGES 4 0.0001
644 EXTRASYSTOLES 1 0.0001
645 RASH MACULAR 5 0.0001
646 MOUTH ULCERATION 3 0.0001
647 OXYGEN SATURATION DECREASED 8 0.0001
648 SKIN EXFOLIATION 12 0.0001
649 PAPULE 1 0.0001
650 DUODENAL ULCER 1 0.0001
651 SINUS TACHYCARDIA 2 0.0001
652 DIVERTICULUM 1 0.0001
653 LIVER FUNCTION TEST INCREASED 3 0.0001
654 BLOOD CREATINE PHOSPHOKINASE INCREASED 4 0.0001
655 GASTROENTERITIS 2 0.0001
656 INFUSION RELATED REACTION 9 0.0001
657 INFLAMMATION 7 0.0001
658 MYALGIA 23 0.0001
659 DRUG EFFECT LESS THAN EXPECTED 2 0.0001
660 DIARRHOEA 87 0.0001
661 PAROSMIA 1 0.0001
662 STOMATITIS 8 0.0001
663 SKIN DISCOLOURATION 6 0.0001
664 ATRIOVENTRICULAR BLOCK 1 0.0001
665 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 1 0.0001
666 HYPOALBUMINAEMIA 1 0.0001
667 THERAPY PARTIAL RESPONDER 2 0.0001
668 FLUSHING 13 0.0001
669 ELECTROCARDIOGRAM ABNORMAL 1 0.0001
670 FURUNCLE 1 0.0001
671 DISORIENTATION 5 0.0001
672 URTICARIA 21 0.0001
673 ATRIAL FLUTTER 1 0.0001
674 BLOOD DISORDER 1 0.0001
675 SENSORY DISTURBANCE 2 0.0001
676 FRUSTRATION TOLERANCE DECREASED 1 0.0001
677 MUSCLE DISORDER 1 0.0001
678 NEURALGIA 3 0.0001
679 MUSCULAR WEAKNESS 14 0.0001
680 POLYURIA 1 0.0001
681 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 22 0.0001
682 HICCUPS 1 0.0001
683 PRURITUS 46 0.0001
684 ASTHENIA 45 0.0001
685 PERICARDITIS 2 0.0001
686 TRANSIENT ISCHAEMIC ATTACK 4 0.0001
687 HAEMATEMESIS 3 0.0001
688 HEMIPARESIS 2 0.0001
689 ALOPECIA 23 0.0001
690 ANAPHYLACTIC SHOCK 3 0.0001
691 UNRESPONSIVE TO STIMULI 3 0.0001
692 DIPLOPIA 3 0.0001
693 ORTHOSTATIC HYPOTENSION 2 0.0001
694 JOINT STIFFNESS 3 0.0001
695 DERMATITIS ATOPIC 6 0.0001
696 HYPOXIA 4 0.0001
697 RENAL FAILURE 15 0.0001
698 CARDIOTOXICITY 1 0.0001
699 GASTROINTESTINAL DISORDER 10 0.0001
700 JAUNDICE 3 0.0001
701 CONFUSIONAL STATE 18 0.0001
702 ANAL INCONTINENCE 1 0.0001
703 MYELOSUPPRESSION 4 0.0001
704 OEDEMA 6 0.0001
705 LEUKOCYTOSIS 2 0.0001
706 SYNCOPE 11 0.0001
707 OVARIAN CANCER 1 0.0001
708 DYSGEUSIA 8 0.0001
709 COGNITIVE DISORDER 5 0.0001
710 DIARRHOEA HAEMORRHAGIC 1 0.0001
711 LEUKAEMIA 1 0.0001
712 DYSPHAGIA 10 0.0001
713 DISEASE RECURRENCE 5 0.0001
714 DEHYDRATION 14 0.0001
715 RED BLOOD CELL COUNT DECREASED 3 0.0001
716 POST PROCEDURAL COMPLICATION 2 0.0001
717 HYPERCHOLESTEROLAEMIA 1 0.0001
718 HERNIA 2 0.0001
719 SURGERY 6 0.0001
720 PHARYNGEAL SWELLING 1 0.0001
721 HEPATOMEGALY 1 0.0001
722 KNEE OPERATION 1 0.0001
723 LIGAMENT SPRAIN 1 0.0001
724 BLADDER DISORDER 1 0.0001
725 BLOOD PRESSURE ABNORMAL 2 0.0001
726 RESPIRATORY DISORDER 3 0.0001
727 HYPOTONIA 1 0.0001
728 VOMITING 47 0.0001
729 PNEUMOCYSTIS JIROVECII PNEUMONIA 1 0.0001
730 HEPATIC FAILURE 3 0.0001
731 EMPHYSEMA 1 0.0001
732 PLEURAL EFFUSION 6 0.0001
733 TASTE DISORDER 2 0.0001
734 BONE MARROW FAILURE 2 0.0001
735 NEUTROPHIL COUNT DECREASED 4 0.0001
736 MOTOR DYSFUNCTION 1 0.0001
737 DEATH 84 0.0001
738 EAR DISCOMFORT 1 0.0001
739 PRODUCT PREPARATION ERROR 2 0.0001
740 LIMB DISCOMFORT 3 0.0001
741 COVID-19 17 0.0001
742 HYPERBILIRUBINAEMIA 1 0.0001
743 POLLAKIURIA 4 0.0001
744 FULL BLOOD COUNT ABNORMAL 1 0.0001
745 RECTAL HAEMORRHAGE 4 0.0001
746 BACK INJURY 1 0.0001
747 PRODUCT DOSE OMISSION ISSUE 27 0.0001
748 PULMONARY THROMBOSIS 1 0.0001
749 TREATMENT NONCOMPLIANCE 5 0.0001
750 GASTROINTESTINAL PAIN 1 0.0001
751 MELAENA 2 0.0001
752 SKIN DISORDER 3 0.0001
753 ORAL PAIN 2 0.0001
754 TYPE 2 DIABETES MELLITUS 3 0.0001
755 ADVERSE DRUG REACTION 8 0.0001
756 BLISTER 5 0.0001
757 TOXICITY TO VARIOUS AGENTS 15 0.0001
758 NAUSEA 70 0.0001
759 SHOCK 2 0.0001
760 ABDOMINAL DISTENSION 9 0.0001
761 DYSPNOEA 48 0.0001
762 BLOOD IRON DECREASED 1 0.0001
763 ATAXIA 1 0.0001
764 ACCIDENT 1 0.0001
765 HYPERLIPIDAEMIA 1 0.0001
766 RASH ERYTHEMATOUS 4 0.0001
767 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 4 0.0001
768 PARAESTHESIA 13 0.0001
769 CONSTIPATION 18 0.0001
770 ILL-DEFINED DISORDER 5 0.0001
771 CEREBRAL INFARCTION 2 0.0001
772 DECREASED APPETITE 19 0.0001
773 INTERCEPTED PRODUCT PREPARATION ERROR 1 0.0001
774 HYPERCALCAEMIA 1 0.0001
775 HYPERSENSITIVITY 15 0.0001
776 GENERALISED OEDEMA 1 0.0001
777 VISUAL IMPAIRMENT 10 0.0001
778 PEMPHIGUS 1 0.0001
779 HOSPITALISATION 12 0.0001
780 CHILLS 9 0.0001
781 NODULE 1 0.0001
782 PSORIASIS 10 0.0001
783 DEPRESSED LEVEL OF CONSCIOUSNESS 3 0.0001
784 ADVERSE REACTION 1 0.0001
785 EYE HAEMORRHAGE 1 0.0001
786 PNEUMONIA 24 0.0001
787 PSORIATIC ARTHROPATHY 3 0.0001
788 PAIN 45 0.0001
789 CORONARY ARTERY OCCLUSION 1 0.0001
790 RESPIRATORY DISTRESS 2 0.0001
791 DIVERTICULITIS 2 0.0001
792 ORAL DISCOMFORT 1 0.0001
793 RHABDOMYOLYSIS 3 0.0001
794 CARDIO-RESPIRATORY ARREST 3 0.0001
795 NECK PAIN 4 0.0001
796 ABDOMINAL DISCOMFORT 12 0.0001
797 PERIPHERAL SWELLING 11 0.0001
798 DYSPEPSIA 7 0.0001
799 LYMPHOPENIA 1 0.0001
800 PARALYSIS 1 0.0001
801 HYPOTENSION 14 0.0001
802 IMPAIRED QUALITY OF LIFE 1 0.0001
803 LETHARGY 4 0.0001
804 ANOSMIA 1 0.0001
805 LIVER FUNCTION TEST ABNORMAL 2 0.0001
806 PRODUCT STORAGE ERROR 6 0.0001
807 MUSCULOSKELETAL STIFFNESS 6 0.0001
808 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 2 0.0001
809 DRY SKIN 9 0.0001
810 COLITIS ULCERATIVE 3 0.0001
811 PULMONARY OEDEMA 3 0.0001
812 HAEMORRHAGE INTRACRANIAL 1 0.0001
813 THERAPEUTIC RESPONSE UNEXPECTED 3 0.0001
814 BLOOD POTASSIUM DECREASED 2 0.0001
815 APHASIA 2 0.0001
816 VERTIGO 4 0.0001
817 HIP ARTHROPLASTY 1 0.0001
818 DEVICE RELATED INFECTION 1 0.0001
819 ACUTE MYELOID LEUKAEMIA 1 0.0001
820 SWELLING 6 0.0001
821 HALLUCINATION, AUDITORY 1 0.0001
822 CYSTITIS 2 0.0001
823 DRUG INTOLERANCE 6 0.0001
824 NIGHT SWEATS 2 0.0001
825 HYPOGLYCAEMIA 3 0.0001
826 BACK DISORDER 1 0.0001
827 PHOTOSENSITIVITY REACTION 1 0.0001
828 BACK PAIN 14 0.0001
829 CYTOMEGALOVIRUS INFECTION 1 0.0001
830 HYPOAESTHESIA 9 0.0001
831 LIP SWELLING 2 0.0001
832 NEOPLASM MALIGNANT 4 0.0001
833 RENAL IMPAIRMENT 5 0.0001
834 CANDIDA INFECTION 1 0.0001
835 THERAPY CESSATION 3 0.0001
836 HAEMATURIA 2 0.0001
837 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 1 0.0001
838 HYPERKALAEMIA 2 0.0001
839 HEAD DISCOMFORT 1 0.0001
840 GALLBLADDER DISORDER 1 0.0001
841 PELVIC PAIN 1 0.0001
842 HAEMATOCHEZIA 3 0.0001
843 CHEST PAIN 10 0.0001
844 CONJUNCTIVITIS 1 0.0001
845 AGRANULOCYTOSIS 1 0.0001
846 HEPATIC CIRRHOSIS 1 0.0001
847 DYSARTHRIA 2 0.0001
848 FRACTURE 1 0.0001
849 GASTRIC ULCER 1 0.0001
850 INCORRECT DOSE ADMINISTERED 12 0.0001
851 MUSCULOSKELETAL DISORDER 1 0.0001
852 HERPES ZOSTER 3 0.0001
853 HYPERTENSION 11 0.0001
854 GLAUCOMA 1 0.0001
855 VISION BLURRED 7 0.0001
856 PAIN IN EXTREMITY 15 0.0001
857 HAEMATOCRIT DECREASED 1 0.0001
858 WEIGHT DECREASED 14 0.0001
859 THROMBOSIS 4 0.0000
860 PRODUCT ADMINISTRATION ERROR 1 0.0000
861 ILLNESS 5 0.0000
862 KNEE ARTHROPLASTY 1 0.0000
863 HALLUCINATION, VISUAL 1 0.0000
864 COUGH 13 0.0000
865 BALANCE DISORDER 4 0.0000
866 INCORRECT PRODUCT ADMINISTRATION DURATION 1 0.0000
867 FAECES DISCOLOURED 1 0.0000
868 INTERVERTEBRAL DISC PROTRUSION 1 0.0000
869 SOMNOLENCE 9 0.0000
870 RHEUMATOID ARTHRITIS 5 0.0000
871 ABDOMINAL PAIN UPPER 9 0.0000
872 UPPER RESPIRATORY TRACT INFECTION 2 0.0000
873 PERICARDIAL EFFUSION 1 0.0000
874 ARRHYTHMIA 2 0.0000
875 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 3 0.0000
876 PRODUCT PRESCRIBING ERROR 1 0.0000
877 PRODUCTIVE COUGH 2 0.0000
878 INFECTION 6 0.0000
879 MENTAL IMPAIRMENT 1 0.0000
880 FIBROMYALGIA 1 0.0000
881 MALAISE 18 0.0000
882 OSTEONECROSIS OF JAW 1 0.0000
883 AGEUSIA 1 0.0000
884 DRY EYE 2 0.0000
885 HOT FLUSH 3 0.0000
886 ABDOMINAL PAIN LOWER 1 0.0000
887 DRUG RESISTANCE 1 0.0000
888 HAEMATOMA 1 0.0000
889 DEPRESSED MOOD 2 0.0000
890 CARDIAC FAILURE CONGESTIVE 3 0.0000
891 PRODUCT USE ISSUE 7 0.0000
892 BLOOD GLUCOSE INCREASED 7 0.0000
893 WHITE BLOOD CELL COUNT DECREASED 4 0.0000
894 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 2 0.0000
895 PROCEDURAL PAIN 1 0.0000
896 ARTHROPATHY 2 0.0000
897 DEMENTIA 1 0.0000
898 CEREBROVASCULAR ACCIDENT 6 0.0000
899 MULTIPLE ORGAN DYSFUNCTION SYNDROME 1 0.0000
900 INTENTIONAL DOSE OMISSION 1 0.0000
901 MYOCARDIAL INFARCTION 6 0.0000
902 INTENTIONAL PRODUCT USE ISSUE 3 0.0000
903 NASAL CONGESTION 2 0.0000
904 LABORATORY TEST ABNORMAL 1 0.0000
905 TACHYCARDIA 3 0.0000
906 CATARACT 2 0.0000
907 THERAPEUTIC RESPONSE DECREASED 2 0.0000
908 NASOPHARYNGITIS 6 0.0000
909 EMOTIONAL DISORDER 1 0.0000
910 EXPOSURE DURING PREGNANCY 2 0.0000
911 CARDIAC DISORDER 3 0.0000
912 NERVOUS SYSTEM DISORDER 1 0.0000
913 ANXIETY 9 0.0000
914 METABOLIC ACIDOSIS 1 0.0000
915 MOVEMENT DISORDER 1 0.0000
916 HIP FRACTURE 1 0.0000
917 CHOLELITHIASIS 1 0.0000
918 HEART RATE INCREASED 3 0.0000
919 BLOOD PRESSURE DECREASED 2 0.0000
920 GAIT INABILITY 1 0.0000
921 ANGER 1 0.0000
922 MEMORY IMPAIRMENT 4 0.0000
923 DEVICE USE ERROR 1 0.0000
924 CEREBRAL HAEMORRHAGE 1 0.0000
925 MOBILITY DECREASED 2 0.0000
926 PANIC ATTACK 1 0.0000
927 DYSURIA 1 0.0000
928 INFLUENZA 3 0.0000
929 EYE SWELLING 1 0.0000
930 DYSPNOEA EXERTIONAL 1 0.0000
931 GAIT DISTURBANCE 5 0.0000
932 DIZZINESS 13 0.0000
933 SEIZURE 3 0.0000
934 PLASMA CELL MYELOMA 1 0.0000
935 PALPITATIONS 3 0.0000
936 ABNORMAL BEHAVIOUR 1 0.0000
937 EXTRA DOSE ADMINISTERED 1 0.0000
938 OEDEMA PERIPHERAL 3 0.0000
939 BLINDNESS 1 0.0000
940 INFLUENZA LIKE ILLNESS 2 0.0000
941 TREATMENT FAILURE 2 0.0000
942 HEADACHE 15 0.0000
943 MENTAL DISORDER 1 0.0000
944 ANGIOEDEMA 1 0.0000
945 LIVER DISORDER 1 0.0000
946 LOWER RESPIRATORY TRACT INFECTION 1 0.0000
947 NEPHROLITHIASIS 1 0.0000
948 OROPHARYNGEAL PAIN 2 0.0000
949 FALL 7 0.0000
950 CONTUSION 2 0.0000
951 CELLULITIS 1 0.0000
952 CHEST DISCOMFORT 2 0.0000
953 HAEMOGLOBIN DECREASED 2 0.0000
954 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 1 0.0000
955 NERVOUSNESS 1 0.0000
956 ECZEMA 1 0.0000
957 MUSCULOSKELETAL PAIN 1 0.0000
958 DRUG INTERACTION 3 0.0000
959 BRADYCARDIA 1 0.0000
960 DISTURBANCE IN ATTENTION 1 0.0000
961 DRUG INEFFECTIVE 24 0.0000
962 TREMOR 3 0.0000
963 FLATULENCE 1 0.0000
964 EYE IRRITATION 1 0.0000
965 IRRITABILITY 1 0.0000
966 JOINT SWELLING 2 0.0000
967 DISCOMFORT 1 0.0000
968 LOSS OF CONSCIOUSNESS 2 0.0000
969 HYPERHIDROSIS 2 0.0000
970 AMNESIA 1 0.0000
971 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 3 0.0000
972 INJURY 1 0.0000
973 AGITATION 1 0.0000
974 BRONCHITIS 1 0.0000
975 WEIGHT INCREASED 3 0.0000
976 EPISTAXIS 1 0.0000
977 HALLUCINATION 1 0.0000
978 ACNE 1 0.0000
979 DEPRESSION 3 0.0000
980 BLOOD PRESSURE INCREASED 2 0.0000
981 PROSTATE CANCER 1 0.0000
982 GASTROOESOPHAGEAL REFLUX DISEASE 1 0.0000
983 GASTROINTESTINAL HAEMORRHAGE 1 0.0000
984 INSOMNIA 3 0.0000
985 NO ADVERSE EVENT 2 0.0000
986 MUSCLE SPASMS 2 0.0000
987 ADVERSE EVENT 1 0.0000
988 BREAST CANCER 1 0.0000
989 MIGRAINE 1 0.0000
990 INJECTION SITE PAIN 3 0.0000
991 ACCIDENTAL EXPOSURE TO PRODUCT 1 0.0000